| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65862-694-50 | 65862-694 | HUMAN PRESCRIPTION DRUG | Metronidazole | Metronidazole | TABLET | ORAL | 20150529 | N/A | ANDA | ANDA203974 | Aurobindo Pharma Limited | METRONIDAZOLE | 250 mg/1 | 50 TABLET in 1 BOTTLE (65862-694-50) |
| 65862-694-99 | 65862-694 | HUMAN PRESCRIPTION DRUG | Metronidazole | Metronidazole | TABLET | ORAL | 20150529 | N/A | ANDA | ANDA203974 | Aurobindo Pharma Limited | METRONIDAZOLE | 250 mg/1 | 1000 TABLET in 1 BOTTLE (65862-694-99) |
| 65862-695-01 | 65862-695 | HUMAN PRESCRIPTION DRUG | Metronidazole | Metronidazole | TABLET | ORAL | 20150529 | N/A | ANDA | ANDA203974 | Aurobindo Pharma Limited | METRONIDAZOLE | 500 mg/1 | 100 TABLET in 1 BOTTLE (65862-695-01) |
| 65862-695-05 | 65862-695 | HUMAN PRESCRIPTION DRUG | Metronidazole | Metronidazole | TABLET | ORAL | 20150529 | N/A | ANDA | ANDA203974 | Aurobindo Pharma Limited | METRONIDAZOLE | 500 mg/1 | 500 TABLET in 1 BOTTLE (65862-695-05) |
| 65862-695-50 | 65862-695 | HUMAN PRESCRIPTION DRUG | Metronidazole | Metronidazole | TABLET | ORAL | 20150529 | N/A | ANDA | ANDA203974 | Aurobindo Pharma Limited | METRONIDAZOLE | 500 mg/1 | 50 TABLET in 1 BOTTLE (65862-695-50) |
| 65862-695-99 | 65862-695 | HUMAN PRESCRIPTION DRUG | Metronidazole | Metronidazole | TABLET | ORAL | 20150529 | N/A | ANDA | ANDA203974 | Aurobindo Pharma Limited | METRONIDAZOLE | 500 mg/1 | 1000 TABLET in 1 BOTTLE (65862-695-99) |